{
  "id": 6426611,
  "title": "BioMarin Reports Positive Phase 3 Results For VOXZOGO",
  "url": "https://urgent.news/2026/09/09/biomarin-reports-positive-phase-3-results-for-voxzogo",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-09T13:45:38.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/biomarin-reports-positive-phase-3-results-voxzogo"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - BioMarin Pharmaceutical Inc. (BMRN) on Wednesday announced positive Phase 3 results for VOXZOGO (vosoritide) in children with hypochondroplasia, with the study meeting its primary endpoint and all secondary efficacy endpoints.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}